Holen Sie sich die Stockscreener-App
64.23
0.47%
0.30
Schlusskurs vom Vortag:
$63.93
Offen:
$63.42
24-Stunden-Volumen:
1.12M
Relative Volume:
0.68
Marktkapitalisierung:
$7.79B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
26.32
EPS:
2.44
Netto-Cashflow:
$421.00M
1W Leistung:
+1.33%
1M Leistung:
-5.35%
6M Leistung:
+1.82%
1J Leistung:
-10.28%
1-Tages-Spanne:
$63.27
$64.32
1-Wochen-Bereich:
$61.95
$64.33
52-Wochen-Spanne:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
64.23 | 7.75B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
787.29 | 97.99B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
328.82 | 63.47B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
CAH
Cardinal Health Inc
|
158.68 | 37.36B | 222.58B | 1.57B | 1.85B | 6.4395 |
|
AHG
Akso Health Group Adr
|
1.63 | 911.67M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein (Nasdaq: HSIC) to present at Stifel Nov 12, Jefferies Nov 18; live webcasts - Stock Titan
Henry Schein to Participate in Upcoming Investor Conferences in November - Bluefield Daily Telegraph
Will earnings trigger a reversal in Henry Schein Inc.Earnings Risk Summary & Weekly Top Gainers Alerts - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Has Henry Schein Inc. found a price floorGDP Growth & Stock Portfolio Risk Control - newser.com
Will Henry Schein Inc. bounce back from current support2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Henry Schein to Report Q3 2025 Earnings - Dentistry Today
Analyzing drawdowns of Henry Schein Inc. with statistical toolsWeekly Stock Report & Precise Buy Zone Identification - newser.com
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET - BioSpace
Earnings Preview: What to Expect From Henry Schein’s Report - Yahoo Finance
Why Henry Schein Inc. stock could be next big winnerTrade Entry Report & Fast Exit and Entry Trade Guides - nchmf.gov.vn
Understanding Henry Schein Inc.’s price movementLong Setup & Fast Momentum Entry Tips - newser.com
Is Henry Schein Inc. stock bottoming outTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo
Can Henry Schein Inc. stock hit analyst price targetsDollar Strength & Fast Gain Stock Trading Tips - newser.com
Chart based analysis of Henry Schein Inc. trendsLayoff News & Weekly Momentum Stock Picks - newser.com
Henry Schein Inc Stock Analysis and ForecastReal-Time Stock Alerts & Capitalize On Momentum - earlytimes.in
Why Henry Schein Inc. stock is trending among retail traders2025 Technical Patterns & Fast Entry Momentum Trade Alerts - nchmf.gov.vn
Gains Recap: Why Henry Schein Inc. stock is considered a top pickWeekly Earnings Recap & Free Accurate Trade Setup Notifications - nchmf.gov.vn
Henry Schein (HSIC): Evaluating Valuation After New Biomerica Deal and Analyst Downgrade - Sahm
How Henry Schein Inc. stock responds to policy changesWeekly Trend Report & Daily Risk Controlled Trade Plans - nchmf.gov.vn
Why Henry Schein Inc. stock is considered a top pickMarket Performance Summary & Free Long-Term Investment Growth Plans - nchmf.gov.vn
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
What dividend safety score for Henry Schein Inc. stockWeekly Investment Summary & Growth Focused Entry Point Reports - nchmf.gov.vn
S P Trends: What dividend safety score for Henry Schein Inc. stockMarket Sentiment Report & Community Consensus Picks - nchmf.gov.vn
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S. - MarketScreener
Henry Schein (HSIC) Gets a Hold from Leerink Partners - The Globe and Mail
Henry Schein Announces Record Date, Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Healt... - ADVFN
Henry Schein Announces $400 Million Increase to Share Repurchase Plan - ADVFN
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. - ADVFN
How Biomerica Deal Expands Henry Schein’s (HSIC) Diagnostic Ambitions and Alters Its Investment Narrative - Yahoo Finance
Assessing Henry Schein (HSIC) Valuation After Recent Share Price Decline - Yahoo Finance
TAG Expands Tech With Planmeca Partnership - Dentistry Today
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's Infoods®? Ibs Test in the U.S - MarketScreener
Biomerica (BMRA) Partners with Henry Schein to Expand IBS Test R - GuruFocus
Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US - MarketScreener
Henry Schein and Biomerica enter into marketing services agreement for Biomerica's inFoods IBS Test in the US - MarketScreener
59.6% of treated patients hit FDA abdominal pain endpoint; Biomerica, Henry Schein to market inFoods® in U.S. (ex NY) - Stock Titan
CFRA downgrades Henry Schein (HSIC) to a Sell - The Globe and Mail
The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide - Financial Times
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.81%
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):